Vagus nerve stimulation for medically refractory absence epilepsy

@article{Arya2013VagusNS,
  title={Vagus nerve stimulation for medically refractory absence epilepsy},
  author={Ravindra Arya and Hansel M. Greiner and Amanda Lewis and Francesco T. Mangano and Cornelia Handy Gonsalves and Katherine D. Holland and Tracy A. Glauser},
  journal={Seizure},
  year={2013},
  volume={22},
  pages={267-270}
}

Tables from this paper

Vagus Nerve Stimulation and Seizure Outcomes in Pediatric Refractory Epilepsy

Pooled evidence supports possible effectiveness of VNS in pediatric DRE, although complete seizure freedom is less common and early referral may be a modifiable factor for desirable seizure outcomes with VNS from a clinical perspective.

Use of Vagus Nerve Stimulator on Children With Primary Generalized Epilepsy

In children with medically intractable primary generalized epilepsy, vagus nerve stimulator is well tolerated and appears to lead to improvement in seizure frequency.

Research progress of vagus nerve stimulation in the treatment of epilepsy

Vagus nerve stimulation (VNS) is one of the neuromodulation methods clinically, which have been approved by the Food and Drug Administration (FDA) and future research directions of VNS for epilepsy are described.

Neuromodulation for Refractory Epilepsy

Three neuromodulation therapies, all using implanted device and electrodes, have been approved to treat adults with drug-resistant focal epilepsy, namely, the vagus nerve stimulation in 1995, deep

A Case of Refractory Absence Epilepsy Precedes Anti-MOG Associated Optic Neuritis

The case of an 11-year-old female with refractory CAE who developed anti-MOG antibody positive ON may suggest that there is an inflammatory component to CAE and that immunomodulatory therapies may have a role in seizure control, in cases of treatment resistant absence epilepsy.

Amantadine for the Treatment of Refractory Absence Seizures in Children

Amantadine can be tried as a safe add-on drug for children with absence epilepsy refractory to multiple drugs and remains seizure free for 6–30 months now.

Vagus nerve stimulation (VNS) therapy update

Therapeutic Options for Childhood Absence Epilepsy

The purpose of this review is to summarize the most recent studies and new concepts concerning CAE treatment, in particular concerning drug-resistant forms of CAE.

Refractory absence seizures: An Italian multicenter retrospective study.

  • E. FranzoniS. Matricardi A. Verrotti
  • Medicine, Psychology
    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
  • 2015

References

SHOWING 1-10 OF 25 REFERENCES

[Vagus nerve stimulation for the treatment of refractory epilepsy].

Amantadine for the treatment of refractory absence seizures in children.

Vagus nerve stimulation for medication-resistant generalized epilepsy

VNS is an effective treatment for medication-resistant generalized epilepsy even in patients as young as 4 years, and patients with higher baseline seizure rates and later ages at epilepsy onset had the best responses to VNS.

Operative and Technical Complications of Vagus Nerve Stimulator Implantation

Surgical and technical complications after implantation of left-sided VNS in patients with therapy-refractory epilepsy and depression and VNS therapy is combined with a wide spread of possible complications are analyzed.

Vagus nerve stimulation for medication-resistant generalized epilepsy. E04 VNS Study Group.

VNS is an effective treatment for medication-resistant generalized epilepsy even in patients as young as 4 years, and patients with higher baseline seizure rates and later ages at epilepsy onset had the best responses to VNS.

Petit mal epilepsy. Results of a prolonged follow-up study of 117 patients.

Since the advent of electroencephalography, it has been clearly demonstrated that all epileptic seizures of brief duration are not petit mal, and concurrent administration of petitmal and major motor anticonvulsants (combined therapy) is recommended.

Therapeutic response of absence seizures in patients of an epilepsy clinic for adolescents and adults

It is found that complete absence control is of great prognostic importance for patients having this seizure type, and with active treatment using, if necessary, high doses of succinimides or valproic acid alone or in combination, excellent results can be achieved even in a patient group biased towards a poor prognosis.

Effect of add-on amantadine therapy for refractory absence epilepsy.